Usana Health Sciences (USNA) EBT (2010 - 2026)

Usana Health Sciences (USNA) has reported EBT for 17 consecutive years, with -$18.9 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBT fell 200.44% year-over-year to -$18.9 million in Q3 2026; TTM through Jul 2026 was $2.5 million, a 96.07% decrease from a year earlier, with the FY2026 full-year figure at $41.5 million, down 45.61% from the prior year.
• EBT was -$18.9 million for Q3 2026 at Usana Health Sciences, down from $15.5 million in the prior quarter.
• Over five years, EBT peaked at $47.2 million in Q1 2022 and troughed at -$18.9 million in Q3 2026.
• A 5-year average of $19.6 million and a median of $20.5 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT increased 16.7% in 2023 and sank 200.44% in 2026, its largest moves.
• Over 5 years, EBT stood at $22.8 million in 2022, then rose by 16.7% to $26.6 million in 2023, then slumped by 60.81% to $10.4 million in 2024, then plunged by 82.8% to $1.8 million in 2025, then slumped by 1153.51% to -$18.9 million in 2026.
• The last three EBT figures came in at -$18.9 million (Q3 2026), $15.5 million (Q2 2026), and $4.2 million (Q1 2026), per Business Quant data.